Language
English
German
^M
Dutch
Spanish
Title:
Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs
Source:
BMC Medical Genetics [1471-2350] yr:2014
Basic
Full text
Full text available via
DOAJ Directory of Open Access Journals
Year:
Volume:
Issue:
Start Page:
Full text available via
PubMed Central
Year:
Volume:
Issue:
Start Page:
Full text available via
PubMed Central Open Access
Year:
Volume:
Issue:
Start Page:
Document delivery
Request document via
Library/Bibliothek
Users interested in this article also expressed an interest in the following:
description
1.
Tod, M.
"Quantitative prediction of the impact of drug interactions and genetic polymorphisms on cytochrome P450 2C9 substrate exposure."
Clinical pharmacokinetics
52.3 (2013): 199-209.
description
2.
Ojha, A.
"A REVIEW ON THE ROLE OF PHARMACOGENOMICS IN DRUG DISCOVERY AND DEVELOPMENT."
International Journal of Pharmaceutical Sciences and Research
7.9 (2016): 3587-3595.
description
3.
Kamdem, L.
"Clinical implications of CYP3A polymorphisms."
Expert Opinion on Drug Metabolism and Toxicology
2.2 (2006): 171-182.
description
4.
Tod, M.
"Quantitative Prediction of Cytochrome P450 (CYP) 2D6-Mediated Drug Interactions."
Clinical pharmacokinetics
50.8 (2011): 519-30.
description
5.
Lagassé, H A Daniel A.
"Recent advances in (therapeutic protein) drug development."
F1000Research.
6: 113-113.
description
6.
Asensi, V.
"Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics."
World Journal of Virology
4.3 (2015): 169-77.
description
7.
Gao, Bruno o.
"Drug Transporters in the Central Nervous System."
Clinical pharmacokinetics
54.3 (2015): 225-242.
description
8.
Tulsyan, S.
"Significant role of CYP450 genetic variants in cyclophosphamide based breast cancer treatment outcomes: a multi-analytical strategy."
Clinica chimica acta
434 (2014): 21-28.
description
9.
Goutelle, S.
"In Vivo Quantitative Prediction of the Effect of Gene Polymorphisms and Drug Interactions on Drug Exposure for CYP2C19 Substrates."
The AAPS journal
15.2 (2013): 415-26.
description
10.
Chen, S.
"Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism - a prospective, randomized, controlled study."
Clinical transplantation
[record in progress].3 (2013): 272-81.
description
11.
Eijk-Van Os PG, Jan G.
"Multiplex Ligation-dependent Probe Amplification (MLPA(R)) for the detection of copy number variation in genomic sequences."
Methods in molecular biology
688 (2011): 97-126.
description
12.
Wang, J.
"CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation."
Expert Review of Molecular Diagnostics
9.4 (2009): 383-90.
description
13.
Surendiran, A.
"Role of pharmacogenomics in drug discovery and development."
Indian journal of pharmacology
40.4 (2008): 137-143.
description
14.
Wilkinson, G R R.
"CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism."
Clinical pharmacology and therapeutics
68.1 (2000): 82-91.
description
15.
Ingelman-Sundberg, M.
"Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms."
Naunyn-Schmiedeberg's archives of pharmacology
369.1 (2003): 89-104.
description
16.
Mehlotra, Rajeev K K.
"Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea."
European journal of clinical pharmacology
62.4 (2006): 267-275.
description
17.
Roses, Allen D.
"Pharmacogenetics in drug discovery and development: a translational perspective."
Nature reviews. Drug discovery
7.10 (2008): 807-817.
description
18.
"Inform elders about grapefruit juice."
ED nursing
13.9 (2010): 102-102.
description
19.
Zhou, Zhou F.
"Polymorphism of human cytochrome P450 2D6 and its clinical significance:"
Clinical Pharmacokinetics
48.12 (2009): 761-804.
description
20.
Davies, Benjamin J., B.
"Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexiline."
British journal of clinical pharmacology
65.3 (2008): 347-354.
View More...
View Less...
Select All
Clear All
Save Citations
Select Format
ProCite
Reference Manager
RefWorks
EndNote
Submit citation export
Advanced
Author
Other articles by this author? -- in
GeoRef
Other articles by this author? -- in
Online Contents Geosciences
Web Search
Find related information in
a Web Search Engine
Excite
Google
HotBot
Ixquick
ZOO
Ask
Yahoo!
Bing
Naver
Search Terms:
Search for related information in
Google Scholar
Article Title
Author Name
Journal Title
Other Search
Search Terms:
A service provided by the
Library of the Wissenschaftspark Albert Einstein
, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.